Nivolumab Immune-Mediated Pneumonitis
Am J Ther
.
2020 Nov/Dec;27(6):e617-e618.
doi: 10.1097/MJT.0000000000000945.
Authors
Rukma Parthvi
1
,
Abhay Singh
2
Affiliations
1
Department of Pulmonary, Critical Care and Sleep Medicine, State University of New York, Buffalo, NY.
2
Department of Oncology, Roswell Park Comprehensive Cancer Centre, Buffalo, NY.
PMID:
32796160
DOI:
10.1097/MJT.0000000000000945
No abstract available
MeSH terms
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms* / drug therapy
Nivolumab / adverse effects
Pneumonia* / chemically induced
Pneumonia* / drug therapy
Substances
Nivolumab